FDA Removes Zantac From Shelves Over Probable Human Carcinogen NDMA
In April of 2020, the FDA determined that Zantac posed a risk to public health due to high amounts of the chemical NDMA. NDMA is a chemical used to makerocket fuel, as well as purposely induce cancer in lab animals for medical studies. NDMA is considered a probable human carcinogen by both the World Health Organization (WHO), and the U.S. Environmental Protection Agency (EPA). The FDA permits a daily intake of 96 nanograms of NDMA, but testing revealed each tablet contained over 3,000,000 nanograms. That’s 3,000 times greater than the FDA’s intake limit. The makers of Zantac have made billions from the drug, and had information that Zantac contained NDMA as early as 1981. They failed to warn consumers, doctors, or government regulators of the risk, and chose to gain profit rather than keep consumers safe.
Types of Cancers Linked to Zantac
Currently these are the known cancers associated with Zantac:
• Bladder Cancer• Breast Cancer• Colorectal Cancer• Esophageal Cancer• Gastric Cancer• Intestinal Cancer• Kidney Cancer• Liver Cancer • Lung Cancer• Pancreatic Cancer• Prostate Cancer• Stomach Cancer• Throat Cancer
If you or a loved one has one of these types of cancer, and used Zantac, contact us today to see if you’re eligible for significant compensation.
Attorney Advertising Disclaimer: The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for advice regarding your individual situation. We invite you to contact us and welcome your calls, letters and electronic mail. Contacting us does not create an attorney-client relationship. Please do not send any confidential information to us until such time as an attorney-client relationship has been established. Prior results do not guarantee a similar outcome.